Bispecific Antibody Pipeline Congress Cancelled
In light of evolving updates and concerns around the coronavirus, we have made the difficult decision to cancel the Bispecific Antibody Pipeline Congress.
This event has always been a great opportunity to bring the bispecific therapeutics community together and advance the field. We are so disappointed to have to make this call, but feel it is the best way to move forward. We thank all of our stakeholders for their support in these uncertain times, and hope to work with all of you again in the future.
Short Courses
Bispecific Antibody Design
Bispecific Antibody Case Studies and Clinical Relevance
Bispecific Antibody Pipeline Congress will unite all the key opinion leaders including regulators, clinicians, and industry experts to deepen our understanding of bispecific therapeutics and exchange innovative ideas to foster meaningful research collaborations. Our 3-day bispecific-focused meeting emphasizes new and unpublished insights that are not widely shared in the scientific community.
Join your peers to discuss platform designs, execution strategies, and share safety data to maximize clinical performance of your candidates in an intimate setting which encourages close interactions and exchange of information.
CORPORATE SPONSORS
CHI offers sponsorships which will maximize your exposure before, during and after each event. We can help you achieve your goals by customizing a package that meets with your objectives and provide you with an integrated marketing program for the entire year. Opportunities include but are not limited to exhibits, presentations, branding, targeted delegate dinners and webinars utilizing our extensive database of over 800,000 Life Sciences professionals.